Article
Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Oct 2012
van Til Niek P, de Boer Helen, Mashamba Nomusa, Wabik Agnieszka, Huston Marshall, Visser Trudi P, Fontana Elena, Poliani Pietro Luigi, Cassani Barbara, Zhang Fang, Thrasher Adrian J, Villa Anna, Wagemaker Gerard
Abstract excerpt
Recombination activating gene 2 (RAG2) deficiency results in severe combined immunodeficiency (SCID) with complete lack of T and B lymphocytes. Initial gammaretroviral gene therapy trials for other types of SCID proved effective, but also revealed the necessity of safe vector design. We report the development of lentiviral vectors with the spleen focus forming virus (SF) promoter driving codon-optimized human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
